JP2017519029A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017519029A5 JP2017519029A5 JP2016575086A JP2016575086A JP2017519029A5 JP 2017519029 A5 JP2017519029 A5 JP 2017519029A5 JP 2016575086 A JP2016575086 A JP 2016575086A JP 2016575086 A JP2016575086 A JP 2016575086A JP 2017519029 A5 JP2017519029 A5 JP 2017519029A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- composition according
- polysaccharide
- combinations
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 21
- 150000004676 glycans Chemical class 0.000 claims 7
- 229920001282 polysaccharide Polymers 0.000 claims 7
- 239000005017 polysaccharide Substances 0.000 claims 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- 239000002562 thickening agent Substances 0.000 claims 3
- 239000000080 wetting agent Substances 0.000 claims 3
- 125000000129 anionic group Chemical group 0.000 claims 2
- 239000007853 buffer solution Substances 0.000 claims 2
- 239000003755 preservative agent Substances 0.000 claims 2
- 230000002335 preservative effect Effects 0.000 claims 2
- OOSZCNKVJAVHJI-UHFFFAOYSA-N 1-[(4-fluorophenyl)methyl]piperazine Chemical compound C1=CC(F)=CC=C1CN1CCNCC1 OOSZCNKVJAVHJI-UHFFFAOYSA-N 0.000 claims 1
- 241000282324 Felis Species 0.000 claims 1
- 206010020850 Hyperthyroidism Diseases 0.000 claims 1
- 229940083916 aluminum distearate Drugs 0.000 claims 1
- RDIVANOKKPKCTO-UHFFFAOYSA-K aluminum;octadecanoate;hydroxide Chemical group [OH-].[Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O RDIVANOKKPKCTO-UHFFFAOYSA-K 0.000 claims 1
- 239000004359 castor oil Substances 0.000 claims 1
- 235000019438 castor oil Nutrition 0.000 claims 1
- 125000002091 cationic group Chemical group 0.000 claims 1
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 claims 1
- KDQPSPMLNJTZAL-UHFFFAOYSA-L disodium hydrogenphosphate dihydrate Chemical compound O.O.[Na+].[Na+].OP([O-])([O-])=O KDQPSPMLNJTZAL-UHFFFAOYSA-L 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims 1
- 230000002209 hydrophobic effect Effects 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- PMRYVIKBURPHAH-UHFFFAOYSA-N methimazole Chemical compound CN1C=CNC1=S PMRYVIKBURPHAH-UHFFFAOYSA-N 0.000 claims 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims 1
- 229920000053 polysorbate 80 Polymers 0.000 claims 1
- 229940068968 polysorbate 80 Drugs 0.000 claims 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 229940083037 simethicone Drugs 0.000 claims 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims 1
- 235000010234 sodium benzoate Nutrition 0.000 claims 1
- 239000004299 sodium benzoate Substances 0.000 claims 1
- 229940074545 sodium dihydrogen phosphate dihydrate Drugs 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 229960002178 thiamazole Drugs 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 239000000230 xanthan gum Substances 0.000 claims 1
- 229920001285 xanthan gum Polymers 0.000 claims 1
- 235000010493 xanthan gum Nutrition 0.000 claims 1
- 229940082509 xanthan gum Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1411310.4 | 2014-06-25 | ||
| GB1411310.4A GB2527555B (en) | 2014-06-25 | 2014-06-25 | Stable methimazole liquid compositions |
| PCT/GB2015/051824 WO2015198033A1 (en) | 2014-06-25 | 2015-06-23 | Thioureylene liquid compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017519029A JP2017519029A (ja) | 2017-07-13 |
| JP2017519029A5 true JP2017519029A5 (enExample) | 2018-07-19 |
| JP6799465B2 JP6799465B2 (ja) | 2020-12-16 |
Family
ID=51410113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016575086A Active JP6799465B2 (ja) | 2014-06-25 | 2015-06-23 | チオウレイレン液体組成物 |
Country Status (19)
| Country | Link |
|---|---|
| US (6) | US10045967B2 (enExample) |
| EP (2) | EP3160441B1 (enExample) |
| JP (1) | JP6799465B2 (enExample) |
| AU (1) | AU2015278962B2 (enExample) |
| CA (1) | CA2952336C (enExample) |
| CY (2) | CY1124535T1 (enExample) |
| DK (2) | DK3160441T3 (enExample) |
| ES (2) | ES2905083T3 (enExample) |
| GB (1) | GB2527555B (enExample) |
| HR (2) | HRP20220078T1 (enExample) |
| HU (1) | HUE056787T2 (enExample) |
| LT (2) | LT3160441T (enExample) |
| NZ (1) | NZ728018A (enExample) |
| PL (2) | PL3160441T3 (enExample) |
| PT (2) | PT3441063T (enExample) |
| RS (2) | RS62850B1 (enExample) |
| SI (2) | SI3441063T1 (enExample) |
| SM (2) | SMT202200043T1 (enExample) |
| WO (1) | WO2015198033A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2527555B (en) | 2014-06-25 | 2018-09-19 | Norbrook Lab Ltd | Stable methimazole liquid compositions |
| GB2702386A (en) * | 2024-11-22 | 2026-06-10 | Liqmeds Worldwide Ltd | An oral non-aqueous solution of carbimazole |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4096174A (en) * | 1977-07-01 | 1978-06-20 | American Cyanamid Company | Anionic naphthalene thioureido-diphenyloxides |
| DE3013839A1 (de) * | 1979-04-13 | 1980-10-30 | Freunt Ind Co Ltd | Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung |
| US5310742A (en) * | 1992-11-30 | 1994-05-10 | Elias Alan N | Uses for thioureylenes |
| AU2001257511A1 (en) * | 2000-05-03 | 2001-11-12 | Joe D'silva | Process and device for producing liquid dosage formulations |
| US20050158367A1 (en) * | 2004-01-16 | 2005-07-21 | The Procter & Gamble Company | Liquid compositions comprising one or more medicaments |
| JP5356831B2 (ja) * | 2006-01-26 | 2013-12-04 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | ネコ科動物の甲状腺機能亢進症を治療するための方法及び組成物 |
| GB2438287A (en) * | 2006-05-19 | 2007-11-21 | Norbrook Lab Ltd | Stable aqueous suspension |
| CA2703008A1 (en) * | 2007-11-15 | 2009-05-22 | Novartis Ag | Anthelmintic paste comprising praziquantel, a macrolide lactone, cyclodextrin and a thickener |
| GB2527555B (en) | 2014-06-25 | 2018-09-19 | Norbrook Lab Ltd | Stable methimazole liquid compositions |
-
2014
- 2014-06-25 GB GB1411310.4A patent/GB2527555B/en active Active
-
2015
- 2015-06-23 NZ NZ728018A patent/NZ728018A/en unknown
- 2015-06-23 RS RS20220049A patent/RS62850B1/sr unknown
- 2015-06-23 PL PL15732908T patent/PL3160441T3/pl unknown
- 2015-06-23 HU HUE18197341A patent/HUE056787T2/hu unknown
- 2015-06-23 HR HRP20220078TT patent/HRP20220078T1/hr unknown
- 2015-06-23 CA CA2952336A patent/CA2952336C/en active Active
- 2015-06-23 SM SM20220043T patent/SMT202200043T1/it unknown
- 2015-06-23 PT PT181973413T patent/PT3441063T/pt unknown
- 2015-06-23 SI SI201531684T patent/SI3441063T1/sl unknown
- 2015-06-23 ES ES15732908T patent/ES2905083T3/es active Active
- 2015-06-23 US US15/321,874 patent/US10045967B2/en active Active
- 2015-06-23 RS RS20211048A patent/RS62321B1/sr unknown
- 2015-06-23 EP EP15732908.7A patent/EP3160441B1/en active Active
- 2015-06-23 WO PCT/GB2015/051824 patent/WO2015198033A1/en not_active Ceased
- 2015-06-23 PT PT157329087T patent/PT3160441T/pt unknown
- 2015-06-23 JP JP2016575086A patent/JP6799465B2/ja active Active
- 2015-06-23 EP EP18197341.3A patent/EP3441063B1/en active Active
- 2015-06-23 DK DK15732908.7T patent/DK3160441T3/da active
- 2015-06-23 DK DK18197341.3T patent/DK3441063T3/da active
- 2015-06-23 SM SM20210487T patent/SMT202100487T1/it unknown
- 2015-06-23 AU AU2015278962A patent/AU2015278962B2/en active Active
- 2015-06-23 LT LTEPPCT/GB2015/051824T patent/LT3160441T/lt unknown
- 2015-06-23 ES ES18197341T patent/ES2884573T3/es active Active
- 2015-06-23 LT LTEP18197341.3T patent/LT3441063T/lt unknown
- 2015-06-23 SI SI201531780T patent/SI3160441T1/sl unknown
- 2015-06-23 PL PL18197341T patent/PL3441063T3/pl unknown
-
2018
- 2018-07-11 US US16/032,870 patent/US20180318262A1/en not_active Abandoned
-
2020
- 2020-04-24 US US16/857,348 patent/US11123327B2/en active Active
-
2021
- 2021-08-02 US US17/391,851 patent/US11738005B2/en active Active
- 2021-08-24 CY CY20211100755T patent/CY1124535T1/el unknown
- 2021-08-25 HR HRP20211354TT patent/HRP20211354T8/hr unknown
-
2022
- 2022-01-26 CY CY20221100062T patent/CY1124961T1/el unknown
-
2023
- 2023-07-11 US US18/350,152 patent/US12171749B2/en active Active
-
2024
- 2024-11-15 US US18/948,686 patent/US20250064785A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX373040B (es) | Composicion farmaceutica acuosa liquida que contiene derivados de ciclodextrina eterificada con conservador. | |
| MX377629B (es) | Composiciones farmacéuticas tópicas. | |
| PE20142314A1 (es) | Composiciones intranasales de dexmedetomidina y metodos de uso de ellas | |
| HRP20200434T1 (hr) | Stabilne vodene formulacije adalimumaba | |
| RU2015141767A (ru) | Композиции и способы для местной доставки простагландинов в подкожный жир | |
| MA38399B2 (fr) | Formulation sous forme de comprimé, utile pour traiter l'insuffisance cardiaque aiguë et l'insuffisance cardiaque chronique | |
| MX2020005942A (es) | Delgada pelicula oral con alta carga de agente activo. | |
| JP2009531457A5 (enExample) | ||
| JP2018523635A5 (enExample) | ||
| HRP20240351T1 (hr) | Cot modulatori i postupci za njihovu uporabu | |
| CL2017003437A1 (es) | Formulación solida oral que contiene irinotecán y método de preparación de la misma | |
| HRP20250792T1 (hr) | Formulacije anhidriranog natrij tiosulfata | |
| CO2020009992A2 (es) | Composiciones oftálmicas que comprenden bilastina, una beta-ciclodextrina y al menos un agente de gelificación | |
| HRP20220793T1 (hr) | Oftalmološki vodeni sastav | |
| HRP20211354T1 (hr) | Tekuće kompozicije tiourilena | |
| RU2016129193A (ru) | Составы на основе берберина и их применение | |
| HRP20201161T1 (hr) | Formulacije sa smanjenom oksidacijom | |
| JP2016534062A5 (enExample) | ||
| FI3554474T3 (fi) | Mikafungiinikoostumuksia | |
| MX2016009475A (es) | Composiciones efectivas contra la conjuntivitis viral. | |
| RU2013110517A (ru) | Средство для профилактики или лечения неалкогольного стеатогепатита | |
| CL2012001545A1 (es) | Composiciones farmacéuticas acuosas que comprende un éster de un prostanoide, un ácido carboxílicoentre 1,2,1,6% de fosfato dibásico de sodio, cloruro de sodio, un agente de solubilización, y el resto de agua, con un ph va de 4 a 8; uso en desordenes oculares como glaucoma, retinopatia diabetica, uveitis, entre otras. | |
| JP2014504628A5 (enExample) | ||
| JP2019504843A5 (enExample) | ||
| NZ627991A (en) | Liquid formulations of hypoglycaemic sulphonamides |